3Ingelman S M, Sim S C, Gomez A, et al. Influence of cytochrome 17450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects [ J ]. Pharmacol Ther, 2007, 116(3) : 496 -526.
4Nakajima M, Iwanari M, Yokoi T. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa ceils [J]. Toxicol Lett, 2003, 144(2) : 247 -56.
5Anttila S, Hakkola J, Tuominen P, et al. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking[ J]. Cancer Res, 2003, 63 (24) : 8623 - 8.
6Hammons G J, Yan S Y, Jin B, et al. Specific site methylation in the 5 '-flanking region of CYP1 A2 interindividual differences in human livers[J]. Life Sci, 2001, 69(7): 839 -45.
7Tokizane T, Shiina H, Igawa M, et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer [J]. Clin Cancer Res, 2005, 11(16) : 5793 -801.
8Jones S M, Boobis A R, Moore G E, et al. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples [ J ]. Biochem Pharmacol, 1992, 43(8) : 1876 -9.
9Gomez A, Karlgren M, Edler D, et al. Expression of CYP2W1 in colon tumors : regulation by gene methylation [ J ]. Pharmacogenomics, 2007, 8(10) : 1315 -25.
10Ronneberg J A, Tost J, Solvang H K, et al. GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas[ J]. Cancer Res, 2008, 68(14) : 5562 -71.
